David Sjöström

David Sjöström is a resident child and adolescent psychiatrist trained in augmented psychotherapy with the MIND Foundation in Berlin. He is currently pursuing a PhD at Lund University researching the use and experience of psychedelics among adolescents in Sweden and within ayahuasca communities in Brazil. David also serves as the study coordinator for psiAN, a newly approved clinical trial investigating the safety and therapeutic potential of two 25 mg doses of psilocybin for adolescents and young adults with relapse in anorexia nervosa.